BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7405552)

  • 1. Do estrogen and progesterone receptors (E2R and PR) in metastasizing endometrial cancers predict the response to gestagen therapy?
    Benraad TJ; Friberg LG; Koenders AJ; Kullander S
    Acta Obstet Gynecol Scand; 1980; 59(2):155-9. PubMed ID: 7405552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma.
    Creasman WT; McCarty KS; Barton TK; McCarty KS
    Obstet Gynecol; 1980 Mar; 55(3):363-70. PubMed ID: 7189047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A; Milkov V
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of gestagen therapy upon estradiol- and progesterone-receptor-level and 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma (author's transl)].
    Pollow K; Boquoi E
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):231-42. PubMed ID: 185824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
    Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
    Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal therapy of endometrial cancer].
    Kato J
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1182-8. PubMed ID: 4057575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    Ehrlich CE; Young PC; Cleary RE
    Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
    Carlson JA; Allegra JC; Day TG; Wittliff JL
    Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J; Ulm R; Bieglmayer C; Husslein P
    Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
    Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
    Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy, and progestin. Clinical correlates.
    Kauppila A; Kujansuu E; Vihko R
    Cancer; 1982 Nov; 50(10):2157-62. PubMed ID: 7127255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
    Kleine W; Maier T; Geyer H; Pfleiderer A
    Gynecol Oncol; 1990 Jul; 38(1):59-65. PubMed ID: 2141316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
    Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
    Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of steroid hormone receptors for 5-year survival in stage II endometrial cancer.
    Friberg LG; Norén H
    Cancer; 1993 Jun; 71(11):3570-4. PubMed ID: 8490906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endometrial cancer and steroid hormone receptors].
    Nyholm HC
    Ugeskr Laeger; 1990 Feb; 152(9):593-7. PubMed ID: 2408223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroid receptors in endometrial cancer.
    Chambers JT
    Yale J Biol Med; 1988; 61(4):339-50. PubMed ID: 3055700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
    Utaaker E; Iversen OE; Skaarland E
    Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basis of gestagen therapy of endometrial carcinoma].
    Trams G
    Dtsch Med Wochenschr; 1978 Mar; 103(13):574-7. PubMed ID: 639688
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.
    McCarty KS; Barton TK; Fetter BF; Woodard BH; Mossler JA; Reeves W; Daly J; Wilkinson WE; McCarty KS
    Cancer; 1980 Dec; 46(12 Suppl):2851-8. PubMed ID: 6256054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.